IntraClear Biologics
gene/enzyme therapy, damage repair, ageing biomarkers
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
gene/enzyme therapy, damage repair, ageing biomarkers
0-100 chain-logic scale · 15 dimensions · scored on public evidence
IntraClear Biologics OÜ, Tallinn, Estonia, Registrite ja Infosüsteemide Keskus 14994429: Network, Financial information Home Premium Services Data Services Login Premium Services Data Services Login European Companies Search Engine Quick Search Power Search Tips & Tricks Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine. Country filter Restrict the search to companies and persons in specific countries by selecting the desired countries here. all countries United Kingdom Austria Belgium Croatia Cyprus Czech Republic Denmark Estonia Finland … Canada, the US and Mexico) ( → NAICS 2017 ) Performance indicator Event filter Submit search Power search is only available to our premium service subscribers. Learn more about the North Data Premium Service Performance indicators Detailed information for these filters is available in our help center article about Performance Indicator filtering . Performance indicator Average salaries per employee Base/share capital Cash on hand Cost of materials Earnings Earnings CAGR Empl
🟢 INTRACLEAR BIOLOGICS OÜ (14994429) - Overview @ Inforegister.ee arrow_back Search for companies and board members CTRL + K search menu Storybook campaign production_quantity_limits Payment failure gavel Payment schedule submission free_cancellation API Language Eesti English По-русски Theme contrast contrast Auto light_mode Light dark_mode Dark Log in login info You are visiting the page while logged out. To see the full information, log in for free. log in INTRACLEAR BIOLOGICS OÜ info Registry code 14994429 2.3 open_in_new Comments 0 Profile visits 250 Company followers 0 Follow Passive co … nfo Data last updated 26.06.2026 Recommended credit limit €0 Indicative payment deadline 0 päeva 6 mo 12 mo 5 yrs MAX Forecast Business risk classes: Reliable Credit risk class I comprises companies that have submitted all their reports and have no tax arrears or these are minimal, in comparison with other companies. There are no or relatively few companies with a poor reputation connected to the board members. This is a reliable company. When selling to this company, use you … get your money back. Unsubmitted declarations info Data last updated 25.06.2026 Deadline Declaration – – Court rulings info Data last updated 26.06.2026 There are no court orders Court hearings info Data last updated 26.06.2026 No court hearings Court decisions info Data last updated 25.06.2026 No court decisions Payment Order Department Regulations info Data last updated 16.06.2026 There are no regulations from the Payment Order Department Enforcement proceedings by bailiffs
Partners | Ageless Partners Skip to content Companies The Rejuvenation Project™ Ageless Fund® Partners Ageless Partners® Ageless Coaches™ Research Ageless Research™ Ageless Education™ Ageless DAOs™ Products All Products Ageless Coaching™ Ageless Guide™ Ageless Hair™ Ageless Supplements™ News Podcasts Pricing Contact Us Companies The Rejuvenation Project™ Ageless Fund® Partners Ageless Partners® Ageless Coaches™ Research Ageless Research™ Ageless Education™ Ageless DAOs™ Products All Products Ageless Coaching™ Ageless Guide™ Ageless Hair™ Ageless Supplements™ News Podcasts Pricing Contact Us &# … ricing Contact Us $ 0.00 0 Cart Companies The Rejuvenation Project™ Ageless Fund® Partners Ageless Partners® Ageless Coaches™ Research Ageless Research™ Ageless Education™ Ageless DAOs™ Products All Products Ageless Coaching™ Ageless Guide™ Ageless Hair™ Ageless Supplements™ News Podcasts Pricing Contact Us Partners Our strategic focus is to build a diverse network of partners with the underlying goal of reverse aging. There is an abundance of information, tools and resou … ! Please enable JavaScript in your browser to complete this form. Email Email * Submit Facebook-f Instagram Youtube Twitter Linkedin-in Discord Github Links Careers Companies Products Pricing Contact Us Careers Companies Products Pricing Contact Us Address 4101 Admiralty Way, Marina Del Rey, CA 90292, United States Contact Us: (323) 536-2866 Open Daily: 9am – 5pm PT Disclaimer : These statements have not been evaluated by the FDA. All products are not intended to diagno
%PDF-1.4 %���� 1 0 obj > endobj 3 0 obj > endobj 7 0 obj > stream x��Yۊ�6}��s ^I�� K`�3�� ��dw!����?D��\�ݥ�L�1�eթҩ*�,���t�� > stream x��[ێ�6}�W�@^E �N6�- ��$@� ����/&e�eE��]�k�Ҝ�g�á �� ��z��3^�� �^�}b������O�}���Mbd����}�-�]������I��]���M09�(! ��]��8�T�S�g��/�є�GN���p'1�����d��5N��� Pf��Dx�����5f.�րx��� ������k'���"�Nc�y�P��9'��(o�����v��Oo�� �)[����MD�����?������-P45��yq��m��=-��Fp��p�h��� S�|feo$�c +a��x{�������~�{&���X �tǃ��� d�A� oB�al�:���~L�W���97���l���|�J *�N�,3z�� T �Dy���VQ㍃@o�7]�!� ����W�� �)����Z���"����sFV� �� �H�
Fight Aging! Newsletter, December 6th 2021 - News - LONGECITY ....................... Google Sign in options Remember me This is not recommended for shared computers Sign in anonymously Don't add me to the active users list Privacy Policy Sign In Create Account ::: --> L onge C ity Advocacy & Research for Unlimited Lifespans .org About UserAgreement Constitution Stewards MembersList Districts Homepage Portal Forum Blogs FacebookPage Media Newsletter P … y, due to their exceptional longevity, the GHRKO mice hold the Methuselah mouse prize for the world's longest-lived laboratory mouse with a lifespan a week short of 5 years of age. The GHRKO mice also exhibit improved healthspan, showing improved cognition and insulin sensitivity, resistance to diabetes, reduced neoplasia, and decreased markers of aging such as adipose tissue (AT) senescence and mTORC1 signaling in liver, kidney, heart, and muscle. Our laboratory recently rep … and interpretation of increasingly accurate data, as well as standardizing the application of these techniques. The Lack of Funding for Chronic Kidney Disease Research is Not an Outlier https://www.fightagi...not-an-outlier/ In this commentary, scientists note the paucity of funding for chronic kidney disease research, given the widespread suffering and death caused by this presently incurable condition. This and many other areas of medicine are seen as solved problems by th … ment does little and many people die doesn't appear to motivate those who could fund progress. There is no sense of urgency and little sense of need. We might make the same comments in the case of atherosclerosis, a condition many consider to be adequately treated and under control, due to the existence of statins and similar drugs that lower LDL cholesterol in the bloodstream, despite the fact that these treatments only somewhat reduce mortality, and that atherosclerosis sti … that they are derived from. These vaPS cells are of high relevance for clinical application because they are contained in unmodified, autologous, adipose-derived regenerative cells (UA-ADRCs). The latter can be obtained from and re-applied to the same patient at the point of care, without the need for further processing, manipulation, and culturi
New York Transhumanist Party | What are the major obstacles that prevent effective anti-aging therapies from being developed
Futurists United | A dinosaur embryo has been found inside a fossilized egg
Partners | Ageless Partners Skip to content Companies The Rejuvenation Project™ Ageless Fund® Partners Ageless Partners® Ageless Coaches™ Research Ageless Research™ Ageless Education™ Ageless DAOs™ Products All Products Ageless Coaching™ Ageless Guide™ Ageless Hair™ Ageless Supplements™ News Podcasts Pricing Contact Us Companies The Rejuvenation Project™ Ageless Fund® Partners Ageless Partners® Ageless Coaches™ Research Ageless Research™ Ageless Education™ Ageless DAOs™ Products All Products Ageless Coaching™ Ageless Guide™ Ageless Hair™ Ageless Supplements™ News Podcasts Pricing Contact Us &# … ricing Contact Us $ 0.00 0 Cart Companies The Rejuvenation Project™ Ageless Fund® Partners Ageless Partners® Ageless Coaches™ Research Ageless Research™ Ageless Education™ Ageless DAOs™ Products All Products Ageless Coaching™ Ageless Guide™ Ageless Hair™ Ageless Supplements™ News Podcasts Pricing Contact Us Partners Our strategic focus is to build a diverse network of partners with the underlying goal of reverse aging. There is an abundance of information, tools and resou … ! Please enable JavaScript in your browser to complete this form. Email Email * Submit Facebook-f Instagram Youtube Twitter Linkedin-in Discord Github Links Careers Companies Products Pricing Contact Us Careers Companies Products Pricing Contact Us Address 4101 Admiralty Way, Marina Del Rey, CA 90292, United States Contact Us: (323) 536-2866 Open Daily: 9am – 5pm PT Disclaimer : These statements have not been evaluated by the FDA. All products are not intended to diagno
VentureRadar 0){if($('#i_b_toggleMore').hasClass('active')){Search_Elastic();}else{Search_DeconstructSearchString();Search_Elastic(false);event.preventDefault();}}else{event.preventDefault();}}" onclick="this.removeAttribute('readonly');" ontouchstart="this.removeAttribute('readonly');" id="i_t_Search" name="VRSearch" readonly> All Ranked Organisation Names Apps and Links Homepage (myVR) Funding Deals Hub Similar Companies App Articles Manage Account Logout Login Free Sign-up Forgotten your password? By continuing, you agree to VentureRadar's Terms of Service , Privacy Policy and Cookie … t these companies to Excel by clicking here. View More With A Free Account Submit or Claim Your Company Register for Free How to Increase your Company's exposure OR Create an Account for More Register for Free View Pricing for full Business Subscription OR More about VentureRadar VentureRadar Database VentureRadar Services VentureRadar for Companies Terms & Conditions Privacy Policy Cookie Policy Copyright ©2024 VentureRadar. All Rights Reserved. Upgr … nditions Privacy Policy Cookie Policy Contact Us Twitter LinkedIn | Submit a Company Directory of Companies Login Free Sign-up for VentureRadar access or By continuing, you agree to VentureRadar's Terms of Service , Privacy Policy and Cookie Policy . Free Sign-up for VentureRadar access You must have cookies enabled to create an account with VentureRadar Refresh (When Cookies Enabled) Return to home page Create a Free Account to Follow Companies To continue, pleas
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
Futurists United | All three of my books are free on Amazon Kindle for three days beginning today
IntraClear Biologics MISSION SCIENCE COMMERCIAL SERVICES AREAS OF WORK RESULTS TEAM ADVISORS CONTACTS EN RU MISSION SCIENCE COMMERCIAL SERVICES AREAS OF WORK RESULTS TEAM ADVISORS CONTACTS EN RU Our goal is to help humanity win the war against age-related diseases MISSION Unlike most current compensatory therapies aimed at reducing the symptoms of age-related diseases, the therapies we are developing are aimed at their very causes — molecular and cellular damage that accumulates in the human body during life. We put damage repair approach forward for the better world. The world without illness … students and young scientists "Actual problems of modern medicine". Received a grant for a scientific approach and innovativeness at International Pirogov Scientific Medical Conference. In 2012-2013 was a member of the Council of the Belarusian State Medical University. In 2013-2014 completed an internship at the state institution "Republican clinical medical center" of Administration President of Belarus. After that worked as a general practitioner. In 2015 finished advance … ork attended international medical conferences, where made presentations on the application of the latest technologies in the diagnosis of various pathologies, as well as studying the nature of pathological changes in the liver tissues in pathologies that manifest as fibrosis. In 2015 created the popular science resource Future Collector , where, in addition to highlighting technological achievements and the development prospects of various fields of science, he carries out e … everaging 6+ years of managerial experience and passion for science aspiring to apply market power to end age-related diseases. He started his career in PwC, then built and rebuilt companies from scratch, starting with consumer goods companies in Russia. Also, he successfully co-founded a socially responsible startup. Last 2 years he worked as Head of Business Development in Health- and BioTech startups, digging deep into the Longevity industry. CHIEF EXECUTIVE OFFICER Dr. Au … in the News ) in addition to a feature story in the New York Times by Pulitzer Prize–winning writer Amy Harmon. A champion of the transhumanist movement, he is the founder of the Betterhumans non-profit, which is the world's first specifically transhumanist biomedical research organization. Led by a collection of high-profile researchers, the or
Search Directions Maps · Tallinn · Medical goods and consumables Medivar Oü No reviews yet Write review Business hours unknown +372 58 14 18 61 Show phone Harju maakond, Tallinn, Pärnu maantee, 139 Save Directions Add photo or video Overview Photos Reviews Features Address Harju maakond, Tallinn, Pärnu maantee, 139 Directions Contacts +372 58 14 18 61 Show phone www.medivar.eu Business hours Business hours unknown Add Edit information Directions Kalev 195 m 4 Kalev Hallivanamehe Tondi Tallinn-Väike Ööbiku Show parking info Features Medical goods and consumables Medical supply store Info about
10 New Bioengineering Companies | StartUs Insights Solutions Discovery Platform Innovation Scouting Startup Scouting Technology Scouting Tech Supplier Scouting Venture Clienting Startup Program Trend Intelligence Business Intelligence Deal Flow API Industries All Industries Automotive Chemical Construction Electronics Energy Finance Healthcare Industry 4.0 Logistics Manufacturing Materials Mobility Packaging Pharma Retail Clients Case Studies Research & Development Corporate Strategy Corporate Innovation Open Innovation New Business Development Product Development Venture Capital Investme
Listen to Transhumanist Party Enlightenment Salon podcast | Deezer Transhumanist Party Enlightenment Salon Total duration: 74 h 50 min Adam Czajkowski Transhumanist Party Enlightenment Salon 115:39 David Primer Transhumanist Party Enlightenment Salon 116:41 TransVision Madrid 2025 Summit Transhumanist Party Enlightenment Salon 110:21 Brandon King Transhumanist Party Enlightenment Salon 120:52 Ariel Feinerman Transhumanist Party Enlightenment Salon 106:36 Chairman's 9th Anniversary Message and Q&A - Gennady Stolyarov II Transhumanist Party Enlightenment Salon 115:01 Timothy Grady Transhuman
Catalyzing a change in how we treat Alzheimer's Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Leal Therapeutics doses fir... AnHorn’s
Lifeboat Foundation | What are the major obstacles that prevent effective anti-aging therapies from being developed
Bioengineering longevity: call for open source approach - Longevity.Technology Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Leal Therapeut
Profiling IntraClear, Aiming to Break Down Lipofuscin in Aged Cells – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives will be saved. Find out how to help » February 25t … s that build up in old cells. The challenge is, as every, convincing someone to fund this approach to rejuvenation past the initial seed stage. Someone will have to: lipofuscin clearance is a broad topic, and it is clearly an important contribution to degenerative aging, particularly in the central nervous system where there are many long-lived cells. There are a lot of different problem molecules in the aggregated mess of metabolic byproducts given the name lipofuscin. This … Living Longer Read the Fight Aging! FAQ Sign up for the Fight Aging! Newsletter Fund Meaningful Aging Research Services Longevity Industry Consulting How to Start a Longevity Biotech Company The Root Causes of Aging Aging is Caused by Damage Accumulating Cross-Links Buildup of Amyloid Between Cells The Failing Adaptive Immune System The Failing Innate Immune System Declining Lysosomal Function Mitochondrial DNA Damage Nuclear DNA Damage Buildup of Senescent Cells Archives and … Feed RSS Comments Feed Using the Fight Aging! Content Feeds Required Reading A Proposal to Accelerate Progress Calorie Restriction and Longevity Cryonics, the Necessary Backup Plan How to Argue for Longevity Science The Odds of Human Longevity Mutations The Need For Activism and Advocacy Nuanced Opposition to the FDA Potential Gene Therapy Targets Predicting the First Rejuvenation Therapies Self-Experiment to Fight Aging! SENS: Bringing an End to Aging Stem Cells and Regener … ht Aging!. Home | FAQ | Fund Research | Services | Investing | Therapies | Newsletter | Archives | Press Room 
Partners | Ageless Partners Skip to content Companies The Rejuvenation Project™ Ageless Fund® Partners Ageless Partners® Ageless Coaches™ Research Ageless Research™ Ageless Education™ Ageless DAOs™ Products All Products Ageless Coaching™ Ageless Guide™ Ageless Hair™ Ageless Supplements™ News Podcasts Pricing Contact Us Companies The Rejuvenation Project™ Ageless Fund® Partners Ageless Partners® Ageless Coaches™ Research Ageless Research™ Ageless Education™ Ageless DAOs™ Products All Products Ageless Coaching™ Ageless Guide™ Ageless Hair™ Ageless Supplements™ News Podcasts Pricing Contact Us &# … ricing Contact Us $ 0.00 0 Cart Companies The Rejuvenation Project™ Ageless Fund® Partners Ageless Partners® Ageless Coaches™ Research Ageless Research™ Ageless Education™ Ageless DAOs™ Products All Products Ageless Coaching™ Ageless Guide™ Ageless Hair™ Ageless Supplements™ News Podcasts Pricing Contact Us Partners Our strategic focus is to build a diverse network of partners with the underlying goal of reverse aging. There is an abundance of information, tools and resou … ! Please enable JavaScript in your browser to complete this form. Email Email * Submit Facebook-f Instagram Youtube Twitter Linkedin-in Discord Github Links Careers Companies Products Pricing Contact Us Careers Companies Products Pricing Contact Us Address 4101 Admiralty Way, Marina Del Rey, CA 90292, United States Contact Us: (323) 536-2866 Open Daily: 9am – 5pm PT Disclaimer : These statements have not been evaluated by the FDA. All products are not intended to diagno
Dein Browser wird nicht mehr unterstützt. Bitte führe ein Upgrade durch. YouTube Music ist nicht für deinen Browser optimiert. Suche nach Updates oder teste Google Chrome. Chrome herunterladen
Partners | Ageless Partners Skip to content Companies The Rejuvenation Project™ Ageless Fund® Partners Ageless Partners® Ageless Coaches™ Research Ageless Research™ Ageless Education™ Ageless DAOs™ Products All Products Ageless Coaching™ Ageless Guide™ Ageless Hair™ Ageless Supplements™ News Podcasts Pricing Contact Us Companies The Rejuvenation Project™ Ageless Fund® Partners Ageless Partners® Ageless Coaches™ Research Ageless Research™ Ageless Education™ Ageless DAOs™ Products All Products Ageless Coaching™ Ageless Guide™ Ageless Hair™ Ageless Supplements™ News Podcasts Pricing Contact Us &# … ricing Contact Us $ 0.00 0 Cart Companies The Rejuvenation Project™ Ageless Fund® Partners Ageless Partners® Ageless Coaches™ Research Ageless Research™ Ageless Education™ Ageless DAOs™ Products All Products Ageless Coaching™ Ageless Guide™ Ageless Hair™ Ageless Supplements™ News Podcasts Pricing Contact Us Partners Our strategic focus is to build a diverse network of partners with the underlying goal of reverse aging. There is an abundance of information, tools and resou … ! Please enable JavaScript in your browser to complete this form. Email Email * Submit Facebook-f Instagram Youtube Twitter Linkedin-in Discord Github Links Careers Companies Products Pricing Contact Us Careers Companies Products Pricing Contact Us Address 4101 Admiralty Way, Marina Del Rey, CA 90292, United States Contact Us: (323) 536-2866 Open Daily: 9am – 5pm PT Disclaimer : These statements have not been evaluated by the FDA. All products are not intended to diagno
Biotech BD & Licensing Events - RxDataLab RxDataLab Data Research About Data Research About SEC Filing Intelligence Biotech BD & Licensing Events Classified 8-K events from SEC EDGAR: licensing agreements, strategic alternatives, M&A signals, and financing activity. Tagged by deal type and linked to company identifiers. Updated 3× daily from primary filings. Request dataset → Live Sample What the data looks like Live data from our pipeline. ABCELLERA BIOLOGICS INC ABCL Jun 17 Licensing AbCellera Biologics Inc. announced a preclinical research collaboration, option, and license agreement. T
Transhumanist Party Enlightenment Salon | Podcast on Spotify
EX-10.6 18 ea020576103ex10-6_osthera.htm LICENSE AGREEMENT, DATED AS OF AUGUST 19, 2020, BY AND BETWEEN OS THERAPIES INCORPORATED AND BLINKBIO, INC Exhibit 10.6 LICENSE AGREEMENT This License Agreement (“ Agreement ”) is effective as of August 19, 2020 (“ Effective Date ”) and is entered into by and between OS Therapies Incorporated, a Delaware corporation (“ Licensee ”), and BlinkBio, Inc. , a Delaware corporation (“ BlinkBio ”). Licensee and BlinkBio may each be referred to herein individually as a “ Party ” and togeth … loping, and commercializing therapeutic products. C. BlinkBio desires to grant to Licensee, and Licensee desires to obtain from BlinkBio, a license to intellectual property controlled by BlinkBio for the development, manufacturing, and commercialization of Products, all under the terms and conditions set forth in this Agreement. Agreement In consideration of the foregoing premises and the covenants herein contained, the receipt and sufficiency of which ar … contract or otherwise. 1.3 “ BLA ” means a biologics license application submitted to the FDA pursuant to 21 C.F.R. §601.2. 1.4 “ BlinkBio Know-How ” means all Know-How that is Controlled by BlinkBio as of the Effective Date or during the Term that is necessary or useful for the research, development, manufacture, or Commercialization of Products. 1.5 “ BlinkBio Materials ” means any … a license to such material, patent right or Know How and (b) has the ability to grant to Licensee access, a license or a sublicense (as applicable) to such material, patent right or Know How as provided for herein without requiring consent from a Third Party or violating the terms of any agreement or other arrangement with any Third Party; provided that, with respect to any material, Patent or Know-How obtained by BlinkBio after the Effective Date from a Third Party, BlinkBio … to Control such material, Patent or Know-How only if it possesses the right to grant such license, sublicense, or other right thereto without being obligated to pay any royalties or other consideration therefor unless Licensee agrees in advance of any grant of rights thereto to pay such royalties or other consideration. “ Controlled &rdquo
Futurists United | http://www.ibtimes.co.uk/robots-will-steal-50-human-jobs-near-future-says-mit-professors-1455088
EX-10.2 6 d29983dex102.htm EX-10.2 EX-10.2 Exhibit 10.2 [***] Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. CONFIDENTIAL Execution Version RESEARCH COLLABORATION AND LICENSE AGREEMENT Between ABCELLERA BIOLOGICS INC. and ELI LILLY AND COMPANY RESEARCH COLLABORATION AND LICENSE AGREEMENT THIS RESEARCH COLLABORATION AND LICENSE AGREEMENT (the “ Agreement ”), effective as of the date this Agreement is duly executed by both Parties (the & … ;6.4.2. 1.10 “ BLA ” means a Biologic License Application, as defined in the United States Federal Food, Drug and Cosmetic Act, 21 U.S.C. §§ 301 et seq., as such may be amended from time to time, and applicable regulations promulgated thereunder by the FDA, or any analogous application or submission with any Regulatory Authority outside of the United States. 1.11 “ Business Day ” means any day other … l, Know-How, or Intellectual Property Right and, in each case, has the power to grant to the other Party access, a license, or a sublicense (as applicable) to the same on the terms and conditions set forth in this Agreement without violating any obligations of the granting Party to a Third Party. 1.20 “ Covered ” or “ Cover ” means, with respect to a Product in a particular country, that the manufacture, use, sale or importation of … n Subjects), 56 (Institutional Review Boards) and 312 (Investigational New Drug Application), as may be amended from time to time, and (d) the equivalent Applicable Laws in any relevant country, each as may be amended and applicable from time to time and in each case, that provide for, among other things, assurance that the clinical data and reported results are credible and accurate and protect the rights, integrity, and confidentiality of trial subjects. 1.31 &nb … .36 “ IND ” means an investigational new drug application filed with the FDA with respect to a Product, or an equivalent application filed with a Regulatory Authority in a country other than the United States to commence a clinical trial of pharmaceutical product. 1.37 “ Intellectual
Ariel Feinerman from Transhumanist Party Enlightenment Salon - Listen on JioSaavn Music What's Hot on JioSaavn New Releases Jag Se Laaj (From “Cocktail 2”) Tera Paisa Mera Paisa (From "Welcome To The Jungle") Bandhu 2.0 (From "Cocktail 2") Deewane Hain (From "Welcome To The Jungle") QEHER (From "Dhamaal 4") Ucha Lamba Kad Forever (From "Welcome To The Jungle") Kaun Hai Woh (From "Baby Do Die Do") Chatni (From "Dhamaal 4") Hai Jawani Toh Ishq Hona Hai Main Vaapas Aaunga Top Playlists Surprise Me Let's Play - Arijit
Lifeboat Foundation What’s New – Lifeboat Foundation Skip to content Lifeboat Foundation: Safeguarding Humanity About Blog Boards Programs Reports Papers Donate Join Us Newsletter Quotes Store Press Releases Toggle sitemap Lifeboat Foundation Sitemap icon-search Main Areas Home About Boards Blog Programs Reports Papers Donate Join Us Newsletter Quotes Store Press Releases Current Programs AIShield AsteroidShield BioShield InfoPreserver InternetShield LifePreserver LifeShield Bunkers NanoShield ScientificFreedomShield SecurityPreserver Space Habitats X-Risks Network Cool Places A-PR … gs Outreach Partnerships Rosetta@Home Volunteer Work About Us Bitcoin Endowment Fund Boards Board of Directors Contact Us Donor List FAQ Finances Guardian Award Interactive Friendly AI Logo Memorial Board Mission Statement Procedures Staff Supplemental FAQ Timeline More Programs AlienShield AntimatterShield BioPreserver BlackHoleShield ClimateShield CommPreserver EnergyPreserver GammaRayShield NeuroethicsShield NuclearShield ParticleAcceleratorShield PersonalityPreserver Seed … alysis to yield unnerving flashes of the future.” — William Gibson, award-winning author of Neuromancer . Jun 18 2026 Read Atomically precise mechanosynthesis of carbon structures on hydrogenated Si(100) by inverted-mode STM , coauthored by our Damian G. Allis . Jun 18 2026 Read ‘Human, all too human’: Will we become hostages to our own minds by implementing universal AI? by our Ariel VA Feinerman . Jun 18 2026 Watch The Physics of FTL Travel by our Is … r Planet is Entering a New Era by our Victor V. Motti . Jun 14 2026 Yuta Aoki , Application Scientist at Matlantis , joins our Physics Board. Jun 14 2026 Christopher Lee Jones , author of Mars Mission I: Surviving the Kessler Effect , joins our Space Settlement Board. Jun 14 2026 Ghanim Alotaibi , Cofounder of the Advance Space Civilization Initiative (ASCI) , joins our Space Settlement Board. Jun 14 2026 Eligar Sadeh , Chief Editor of the academic journal Astropolitics , joi … hat will resonate with all reader—Dorothie and Marty Hellman persuasively apply their life lessons to the domain of foreign affairs. “We are often puzzled when peoples of two nations seem to get along, while their governments are at loggerheads. The Hellmans have much to say about why this does not have to be so.”—A
Aging Companies (for profits) - Google Sheets Die Datei kann in Ihrem Browser nicht geöffnet werden, weil JavaScript nicht aktiviert ist. Aktivieren Sie JavaScript und laden Sie die Seite noch einmal. Diese Browserversion wird nicht mehr unterstützt. Installieren Sie bitte einen unterstützten Browser. Aging Companies (for profits) Tab Extern Freigeben Anmelden Datei Bearbeiten Ansicht Einfügen Format Daten Tools Erweiterungen Hilfe Bedienungshilfen Fehlerbehebung Nicht gespeicherte Änderungen in Drive &n … NA interference (RNAi) therapieus to silence disease-specific genes, with broad application to many age-related disease areas FDA approved Tx proteostasis (h)ATTR(-CM), AD, HD, ALS, T2D, MASH, NAFLD, hypercholesterolemia, hypertension humans 82 ATTR, APP, PCSK9, AGT, HTT, SOD-1, HSD17B13 siRNA pharma Yvonne Greenstreet, Kevin Fitzgerald Boston yes ALNY $39,142 2100 2442 2002 >$100M Onpattro, Amvuttra, Leqvio science presentations 2025-02-02 2024-08-15 *Borderline: Broad pr